Dallas, Texas 02/11/2014 (FINANCIALSTRENDS) – Rite Aid Corporation(NYSE:RAD) the Camp Hill, PA-based drugstore chain is involved in the sale of prescription drugs as well as many other front end products. The company has over the past year recorded prescription drug sale of over 67.6% over its other sales. The company has also noted that the front-end sale is currently recorded at 32.4% of the overall sales in the financial year of 2013.
Front End products seller as well
Rite Aid Corporation (NYSE:RAD) front end products are typically those types of products such as health, personal care items, medications, cosmetics, household items as well as seasonal purchases, greeting cards, besides other convenience products. The company is also interested in photo processing sector as well.
Private brands of Rite Aid perform well
Rite Aid Corporation (NYSE:RAD) also owns several private brands and it has found to return good earnings of the same as well. In the second-half of the year, the company has acquired Kings Pharmacy East Inc, which is also owns and operates pharmacies.
Jumps recognized in January, following analyst upgrades
Rite Aid Corporation (NYSE:RAD) currently trades on the stock market at prices ranging between $5.57 and $5.69. The stock has recorded prices for the 52 week as $1.52 and $6.15 high and low respectively. The average volume for the stock was 22.56million.
Rite Aid Corporation (NYSE:RAD) has a market cap of 5.45 billion and PE of 19.08. EPS for the stock is recorded at 0.3 and Beta is 2.38. The company has in the month of January received higher rating by most analysts. In the first week of January, JP Morgan preferred to post overweight for this pharma stock. Following which, the share prices rose by over 2.9% against a Price Target of $6.50. Besides, Deutsche too released positive rating for the company, leading to intense upside